← Back to patent-cliff list
CAS 24549-12-0
methyl 3-(methylamino)propanoate
Codes: IBAN-019
Application context (from source-drug indications)
OsteoporosisIbandronate Sodium Hydrate/ColecalciferolOsteoporosisIbandronate Sodium HydratePostmenopausal osteoporosisIbandronate Sodium HydrateHypercalcaemiaIbandronate Sodium HydrateBone injuryIbandronate Sodium HydrateBreast cancerIbandronate Sodium HydrateMetastatic cancerIbandronate Sodium Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ibandronate Sodium Hydrate/Colecalciferol | Tier C — Watch / trade | - |
| Ibandronate Sodium Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-bromopentane→acrylic acid→methyl 3-(methylamino)propanoate→[1-hydroxy-3-(methylamino)-1-phosphonopropyl]phosphonic acid
1-bromopentane→acrylic acid→methyl 3-(methylamino)propanoate→[1-hydroxy-3-(methylamino)-1-phosphonopropyl]phosphonic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.